Cargando…

Reliability evaluation of four different assays for therapeutic drug monitoring of infliximab levels

BACKGROUND: The aim of this study was to evaluate reliability of four different assays for measuring infliximab trough levels and antibodies to infliximab (ATI). METHODS: In this non-interventional, cross-sectional study including IBD patients, infliximab levels and ATI were measured using four diff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pérez, Irene, Fernández, Lidia, Sánchez-Ramón, Silvia, Alba, Cristina, Zatarain, Ana, Cañas, Mercedes, López, Olga N., Olivares, David, Rey, Enrique, Taxonera, Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048662/ https://www.ncbi.nlm.nih.gov/pubmed/30034528 http://dx.doi.org/10.1177/1756284818783613

Ejemplares similares

Recurrent granulomatous cheilitis associated with Crohn’s disease successfully treated with ustekinumab: case report and literature review
por: Taxonera, Carlos, et al.
Publicado: (2020)

Su1496: SARS-COV-2 INFECTION IN IBD: PANDEMIC WAVES AND PREDICTORS OF SEVERE OR PERSISTENT COVID-19
por: Taxonera, Carlos, et al.
Publicado: (2022)

What Is the Incidence of COVID-19 in Patients With IBD in Western Countries?
por: Taxonera, Carlos, et al.
Publicado: (2021)

Comparative Evaluation of Four Commercially Available Immunoassays for Therapeutic Drug Monitoring of Infliximab and Adalimumab
por: Rissel, Florian, et al.
Publicado: (2023)

Clinical Impact of Corrections to Infliximab and Adalimumab Monitoring Results with the Homogeneous Mobility Shift Assay
por: Papamichael, Konstantinos, et al.
Publicado: (2020)

Clinical performance of an infliximab rapid quantification assay
por: Magro, Fernando, et al.
Publicado: (2017)

Response to Infliximab in Crohn's Disease: Genetic Analysis Supporting Expression Profile
por: Medrano, Luz María, et al.
Publicado: (2015)

Infliximab reduces Zaprinast-induced retinal degeneration in cultures of porcine retina
por: Martínez-Fernández de la Cámara, Cristina, et al.
Publicado: (2014)

Therapeutic Drug Monitoring of Infliximab in Acute Severe Ulcerative Colitis
por: Gordon, Benjamin L., et al.
Publicado: (2023)

Can COVID-19 Trigger De Novo Inflammatory Bowel Disease?
por: Taxonera, Carlos, et al.
Publicado: (2021)

Selected reaction monitoring assays in mesenchymal stem cells from osteoarthritis patients
por: Camafeita, Emilio, et al.
Publicado: (2014)

Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assays
por: Afonso, Joana, et al.
Publicado: (2016)

Infliximab concentration monitoring improves the control of disease activity in rheumatoid arthritis
por: Mulleman, Denis, et al.
Publicado: (2009)

The Clinical and Cost-Effectiveness of 4 Enzyme-Linked Immunosorbent Assay Kits for Monitoring Infliximab in Crohn Disease Patients: Protocol for a Validation Study
por: Langford, Thomas, et al.
Publicado: (2018)

Infusion reaction to infliximab biosimilar after transitioning from infliximab
por: Kashlan, Reem, et al.
Publicado: (2020)

Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases
por: Ducourau, Emilie, et al.
Publicado: (2011)

Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab
por: Fitzgerald, Timothy, et al.
Publicado: (2021)

Real-World Experience With Proactive Therapeutic Drug Monitoring During Infliximab Reintroduction
por: Normatov, Inessa, et al.
Publicado: (2021)

A comparative study of PD-L1 immunohistochemical assays with four reliable antibodies in thymic carcinoma
por: Sakane, Tadashi, et al.
Publicado: (2018)

Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
por: Subedi, Smriti, et al.
Publicado: (2019)

Development and validation of enzyme-linked immunosorbent assays for the measurement of infliximab and anti-drug antibody levels
por: Xiang, Dong, et al.
Publicado: (2023)

Impact of Introducing Infliximab Biosimilars on Total Infliximab Consumption and Originator Infliximab Prices in Eight Regions: An Interrupted Time-Series Analysis
por: Peng, Kuan, et al.
Publicado: (2023)

Infliximab in ulcerative colitis
por: Levin, Avi, et al.
Publicado: (2008)

Failure of Isoniazid Chemoprophylaxis during Infliximab Therapy
por: Fernández-Guerrero, Manuel L., et al.
Publicado: (2007)

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease
por: Vande Casteele, Niels, et al.
Publicado: (2015)

Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn's Disease
por: Gomes, Luis Eduardo Miani, et al.
Publicado: (2019)

DAS28: a useful instrument to monitor infliximab treatment in patients with rheumatoid arthritis
por: van Riel, Piet LCM, et al.
Publicado: (2005)

Behçet's pulmonary artery aneurysms treated with infliximab and monitored with the 6-min walk test
por: Kotecha, Jalpa, et al.
Publicado: (2016)

Plasma infliximab monitoring contributes to optimize Takayasu arteritis treatment: a case report
por: Masui, Sho, et al.
Publicado: (2019)

Therapeutic Drug Monitoring and Outcome of Infliximab Therapy in Pediatric Onset Inflammatory Bowel Disease
por: Kolho, Kaija-Leena
Publicado: (2021)

Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn’s Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab
por: Sorrentino, Dario, et al.
Publicado: (2015)

Validity and Reliability of Four Parent/Patient–Reported Outcome Measures for Juvenile Idiopathic Arthritis Remote Monitoring
por: van Dijkhuizen, E. H. Pieter, et al.
Publicado: (2022)

Clinical monitoring: infliximab biosimilar CT-P13 in the treatment of Crohn’s disease and ulcerative colitis
por: Keil, Radan, et al.
Publicado: (2016)

Infliximab in the treatment of Crohn’s disease
por: Poggioli, Gilberto, et al.
Publicado: (2007)

Infliximab: 12 years of experience
por: Smolen, Josef S, et al.
Publicado: (2011)

Treatment of severe psoriasis with infliximab
por: Leman, JA, et al.
Publicado: (2008)

Infliximab in the treatment of rheumatoid arthritis
por: Perdriger, A
Publicado: (2009)

Infliximab in the treatment of ankylosing spondylitis
por: Grainger, Rebecca, et al.
Publicado: (2007)

Response of Fibroblastic Rheumatism to Infliximab
por: Romiti, Ricardo, et al.
Publicado: (2009)

Infliximab for the treatment of refractory scleritis
por: Doctor, Priyanka, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_lrr9hpul9tjh5j8r8a3gup9gm8